BPC-157, a synthetic pentadecapeptide, has shown promise in preclinical studies for its potential regenerative and protective properties. However, when it comes to safety for women, particularly during pregnancy or breastfeeding, the data is scarce. The research does not provide specific information regarding the safety of BPC-157 for women in these circumstances, and the consensus among AI assistants is that BPC-157 should be avoided during pregnancy and breastfeeding due to insufficient fetal and infant safety data [3].
What the AI assistants say
The AI assistants collectively agree that BPC-157 is not known to have female-specific safety problems, but this is mostly due to limited human data rather than proven safety. For pregnancy and breastfeeding, they concur that BPC-157 should be avoided because there are no adequate human reproductive, fetal-development, placental-transfer, or breast-milk safety data [3]. They also highlight that BPC-157’s biological activity, which includes effects on angiogenesis, inflammation, and tissue growth, makes its use during pregnancy potentially risky without proper safety data [3].
What the research actually shows
The research corpus does not provide specific information on the safety of BPC-157 for women, or its use during pregnancy or breastfeeding. While BPC-157 has shown safety in clinical trials for inflammatory bowel disease and wound healing in adults, this information does not extend to pregnant or breastfeeding women [1]. The lack of information on the safety of BPC-157 during pregnancy and breastfeeding is a common gap in medical research, and caution is generally recommended when using any medication or substance during these periods [2].
Where the AI consensus and the research diverge
The AI assistants provide a more detailed analysis of the potential risks associated with BPC-157 use during pregnancy and breastfeeding, citing the peptide’s effects on various biological pathways that are critical during these periods. In contrast, the research corpus is more general, emphasizing the lack of specific data and the need for caution. Both sources agree on the absence of safety data and the need for caution, but the AI assistants offer a more nuanced understanding of the potential risks based on BPC-157’s mechanisms of action.
Bottom line: Based on the available research and AI assistant analysis, there is no specific information on the safety of BPC-157 for women, or its use during pregnancy or breastfeeding. It is important to exercise caution when using any medication or substance during these periods due to the potential risks to both the mother and the developing fetus or infant. [1][2].
References
- Beneficial effect of a novel pentadecapeptide BPC 157 on — Predrag Sikirić
- Boundless Upgrade Your Brain, Optimize Your Body and Defy — Ben Greenfield
- Clinical Research Involving Pregnant Women
- Hepatoprotective effect of BPC 157, A 15-aminoacid peptide — Predrag Sikiric
- Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157. Vascular recruitment and gastrointestinal tract
- Pentadecapeptide BPC 157 (PL 14736) improves ligament — Tomislav Cerovecki
- Pentadecapeptide BPC 157 Interactions with Adrenergic and — Vjekoslav Jagic
- Pentadecapeptide BPC 157 and the esophagocutaneous fistoma healing therapy
- Pottenger's Cats
- The Longevity Paradox How to Die Young at a Ripe Old Age — Dr Steven R Gundry, M D
- The effect of pentadecapeptide BPC 157, H-blockers — Predrag Sikiric
- The pharmacological properties of the novel peptide BPC 157 — P Sikiric（Affiliation Department of Pharmacology, Medical
- Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157
- Traumatic brain injury in mice and pentadecapeptide BPC 157 — Mario Tudor
Continue your research
Part of our BPC-157: Safety, Side Effects & Regulation guide.
- What are the known side effects of BPC-157 in humans?
- Does BPC-157 increase cancer risk because of its angiogenic (blood-vessel-growing) effects?
- Why hasn't BPC-157 been approved by the FDA, and why did the FDA restrict compounding it?
- Is BPC-157 banned by WADA for athletes, and why?
Related topics:
- Does BPC-157 reduce scar tissue formation during healing?
- What do athletes report about BPC-157 for sports injuries, and does it match the research?
- What is the typical BPC-157 dosage people use, and what dosing does the research support?